Optina Diagnostics
OrganisationROR
People
Lead investigator
Sources: openalex.org
Grants and prizes
Alzheimer's Drug Discovery Foundation
Diagnostics Accelerator, Validation of the Retinal Deep Phenotyping(TM) platform for the detection of the likely cerebral amyloid status to aid in the diagnosis of Alzheimer’s disease, ADDF-21556478, US$2.1m, 2022–2024, 1 Jan 2022
Sources: openalex.org
Named in competing interests
Plasma Phosphorylated Tau 217 Percentage by Race and Ethnicity in Preclinical Alzheimer Disease
Fees or honoraria, 12 Oct 2026
Sources: pubmed.ncbi.nlm.nih.gov